Tom Brady Just Joined the Wellness Illusion

Click here if you need help quitting psychiatric medications

Tom Brady has just stepped into the wellness industry as a “chief wellness officer,” and I believe most people have no idea what that actually means.

In this video, I explain why Tom Brady’s involvement with an online pharmacy may be part of the next major drug advertising scandal in American healthcare.

This is not about football.

This is about how medications are being marketed directly to the public, using celebrity trust to bypass the safeguards that are supposed to protect patients.

The company at the center of this discussion helps people access weight loss drugs known as GLP-1s. The advertising sounds harmless. “Feel better, perform better, protect your long-term health.” But those are marketing claims, not drug labeling claims backed by clinical trial data. That distinction matters.

I break down how online pharmacies function as middlemen that appear to operate outside traditional drug advertising regulations. This creates a loophole where broad, feel-good claims can be made that would never be allowed in standard pharmaceutical advertising.

These platforms are not focused on diet, exercise, sleep, or lifestyle change. They are focused on getting people onto medications.

And this issue goes far beyond weight loss.

I also discuss how similar tactics are now being used in mental health. Some online pharmacies market antidepressants as solutions for burnout and stress, normalizing medication as a first response to ordinary human distress while offering little or no psychotherapy or non-drug alternatives.

As a psychiatrist, I find this deeply concerning.

Normal emotional struggles are being medicalized.

Celebrities are being used to legitimize pharmaceutical solutions.

And patients are being nudged toward drugs without fully understanding risks, limitations, or alternatives.

This is not about blaming celebrities. Most of them likely do not understand the implications of what they are promoting.

But direct-to-consumer drug advertising, especially when driven by trusted public figures, represents a serious public health risk. And I believe regulation in this area is coming.

In this video, I explain why.

If you care about informed consent, ethical medicine, and protecting patients from harm, this is a conversation we need to have.

Get our free tapering course

Join +6000 people learning how to taper on our newsletter

CONNECT WITH ME:

LINKS MENTIONED

[LINKS MENTIONED]

Timestamps:

[INSERT TIMESTAMPS]

DISCLAIMER: All the information on this channel is for educational and/or entertainment purposes and not intended to be specific/personal medical advice from me to you. Watching the videos, or getting answers to comments/question, does not establish a doctor-patient relationship. If you have your own doctor, these videos can maybe help you prepare for your discussion with him. We do our best to spread awareness with these videos, but for legal reasons we can’t answer health questions in the comments. If you leave questions, we’ll make videos about common questions in the future! If we catch incorrect health information, hate speech, illegal solicitation of drugs in the comments, we will remove them.

#psychiatricmeds #ssri #antidepressants